Article
Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.
The American journal of tropical medicine and hygiene - 1 Apr 2007
Alker Alisa P, Lim Pharath, Sem Rithy, Shah Naman K, Yi Poravuth, Bouth Denis Mey, Tsuyuoka Reiko, Maguire Jason D, Fandeur Thierry, Ariey Frederic, Wongsrichanalai Chansuda, Meshnick Steven R
Abstract excerpt
Artemisinin combination therapies (ACTs) have recently been adopted as first-line therapy for Plasmodium falciparum infections in most malaria-endemic countries. In this study, we estimated the association between artesunate-mefloquine therapy failure and genetic changes in the putative transporter, pfmdr1. Blood samples were acquired from 80 patients enrolled in an 2004 in vivo efficacy study in Pailin,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
